News

Vaxxas has landed $90 million in debt and equity funding to develop technology that could replace the flu jab and other ...
Sartorius Stedim Biotech has agreed to invest $3m in Nanotein Technologies, a US-based company engaged in the development of ...
Perhaps it’s just the summer slowdown, but it’s been a light month for executive hires in the pharma and biotech world.